Beijing Mabworks Biotech Co., Ltd.

This study tests a new drug called MIL116 in healthy volunteers and people with IgA nephropathy, a kidney disease. The drug targets a protein to reduce kidney damage. The goal is to check safety and how well it works over several weeks.

This study tests a new drug called MIL62 for people with systemic lupus erythematosus (SLE), an autoimmune disease. About 316 adults with active lupus will receive either MIL62 or a placebo to see if the drug safely reduces disease activity and allows lower steroid doses. The mai…